Navigating Regulatory Pitfalls at the Nexus Between Home Health and Infusion
This Feature Article is brought to you by AHLA's Post-Acute and Long Term Services Practice Group.
- March 01, 2026
- Jaya F. White , Quarles & Brady LLP
- Kiel Zillmer , Quarles & Brady LLP
Traditional home health has experienced significant change in recent years, driven primarily by the expansion of creative business models, including a home infusion model where a health care practitioner administers infusion medications in a patient’s home. While the home health industry has expanded, the laws, regulations, and certifications applicable to traditional home health have not caught up with this evolution. To further complicate the matter, infusion providers are now exploring yet another service delivery mechanism—the ambulatory infusion suite (AIS)—in which infusion treatment is administered at a designated site outside of a patient’s home. Operating in a gray area where the legal landscape has not kept pace requires infusion providers to analyze all potentially applicable laws and associated requirements and make determinations regarding the best path forward to ensure compliant business operations.
ARTICLE TAGS
You must be logged in to access this content.